Efficacy of pentoxifylline for the treatment of bipolar I/II patients with treatment-resistant depression: A proof-of-concept, randomized, double-blind, placebo-controlled trial
The current proof of concept study found that in terms of overall anti-depressant effectiveness in bipolar patients with TRD, PTX is not superior to placebo. However, it may improve depressive mood in a subpopulation of subjects with a higher pretreatment inflammatory profile.
Authors
- Teshk Shawis
- Tavgah Ahmed Merza Mohammad
- Talar Ahmed Merza Mohammad
Institutions
- Hawler Medical University (IQ)
- University of Kurdistan Hewler (IQ)
- University of Sulaimani (IQ)
Publication Details
- Journal
- Brain Research Bulletin
- Published
- 2024-08-10
- DOI
- https://doi.org/10.1016/j.brainresbull.2024.111047
- Citations
- 8
- Primary Topic
- Bipolar Disorder and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.08